Evidence map›Paper›PMID 32023824›Full record

ArticleInternational journal of molecular sciences2020

Unfavorable Reduction in the Ratio of Endothelin B to A Receptors in Experimental 5/6 Nephrectomy and Adenine Models of Chronic Renal Insufficiency.

Suvi Törmänen, Päivi Lakkisto, Arttu Eräranta, Peeter Kööbi, Ilkka Tikkanen, Onni Niemelä, Jukka Mustonen, Ilkka Pörsti

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 47% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Suvi TörmänenFaculty of Medicine and Health Technology, Tampere University, 33520 Tampere, Finland.
Päivi LakkistoMinerva Institute for Medical Research, 00290 Helsinki, Finland.ORCID 0000-0001-9935-6573
Arttu ErärantaFaculty of Medicine and Health Technology, Tampere University, 33520 Tampere, Finland.
Peeter KööbiFaculty of Medicine and Health Technology, Tampere University, 33520 Tampere, Finland.
Ilkka TikkanenMinerva Institute for Medical Research, 00290 Helsinki, Finland.
Onni NiemeläFaculty of Medicine and Health Technology, Tampere University, 33520 Tampere, Finland.
Jukka MustonenFaculty of Medicine and Health Technology, Tampere University, 33520 Tampere, Finland.
Ilkka PörstiFaculty of Medicine and Health Technology, Tampere University, 33520 Tampere, Finland.ORCID 0000-0002-4905-7564
Tampere University · FIUniversity of Helsinki · FI

Funding

the Competitive Research Funding of the Hospital District of Helsinki and Uusimaa -the Competitive State Research Financing of the Expert Responsibility Area of Tampere University Hospital -the Emil Aaltonen Foundation -the Finnish Foundation for Cardiovascular Research -the Finnish Foundation for Laboratory Medicine -the Finnish Kidney Foundation -the Finska Läkaresällskapet -the Liv och Hälsa Foundation -the Pirkanmaa Regional Fund of the Finnish Cultural Foundation -
6 · The paper itself

Abstract

Chronic renal insufficiency (CRI) is characterized by increased endothelin 1 (ET-1) synthesis. We studied rat kidney endothelin receptor A (ETA) and receptor B (ETB) expressions after 12 and 27 weeks of 5/6 nephrectomy, and after 12 weeks of 0.3% adenine diet, representing proteinuric and interstitial inflammation models of CRI, respectively. Uric acid and calcium-phosphate metabolism were modulated after 5/6 nephrectomy, while ETA blocker and calcimimetic were given with adenine. Endothelin receptor mRNA levels were measured using RT-qPCR and protein levels using autoradiography (5/6 nephrectomy) or ELISA (adenine model). Both 12 and 27 weeks after 5/6 nephrectomy, kidney cortex ETA protein was increased by ~60% without changes in ETB protein, and the ETB:ETA ratio was reduced. However, the ETB:ETA mRNA ratio did not change. In the adenine model, kidney ETA protein was reduced by ~70%, while ETB protein was suppressed by ~95%, and the ETB:ETA ratio was reduced by ~85%, both at the protein and mRNA levels. The additional interventions did not influence the observed reductions in the ETB:ETA ratio. To conclude, unfavorable reduction in the ETB:ETA protein ratio was observed in two different models of CRI. Therefore, ETA blockade may be beneficial in a range of diseases that cause impaired kidney function.

Indexed as

AdenineAnimalsCalciumDisease Models, AnimalGene Expression RegulationKidney CortexMaleNephrectomyPhosphatesRatsReceptor, Endothelin AReceptor, Endothelin BRenal Insufficiency, ChronicUric AcidAdenineCalciumednrb protein, ratPhosphatesReceptor, Endothelin AReceptor, Endothelin BUric Acidcalciumchronic kidney diseasechronic renal insufficiencycinacalcetcreatinineendothelin receptor Aendothelin receptor Bparicalcitolphosphatesitaxentanuric acid

Identifiers

PMID32023824
PMCPMC7037353
OpenAlexW3003740327

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.